GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will change the treatment paradigm.

Enterome has secured $19m in new private funding to progress its EO2463 OncoMimics immunotherapy, targeting iNHL.

Geopolitical disturbances across the supply chain are further complicating the complex pharma customs process.

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

The FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...

SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

Decreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.

The UK’s National Health Service (NHS) is receiving a £29bn ($39.1bn) funding boost, reflecting a 3% annual rise on current ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in MASH diagnosis and care.

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

Antares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.

The Scottish Medicines Consortium (SMC) has accepted Outlook Therapeutics’ Lytenava to treat wet age-related macular ...